A detailed history of Squarepoint Ops LLC transactions in Incyte Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 24,444 shares of INCY stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,444
Previous 1,344,579 98.18%
Holding current value
$1.74 Million
Previous $81.5 Million 98.02%
% of portfolio
0.0%
Previous 0.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $75.7 Million - $90.6 Million
-1,320,135 Reduced 98.18%
24,444 $1.62 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $45.1 Million - $56.1 Million
880,649 Added 189.82%
1,344,579 $81.5 Million
Q1 2024

May 15, 2024

SELL
$56.55 - $66.59 $10.5 Million - $12.4 Million
-185,586 Reduced 28.57%
463,930 $26.4 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $4.54 Million - $5.58 Million
-86,977 Reduced 11.81%
649,516 $40.8 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $30.8 Million - $38.1 Million
505,084 Added 218.26%
736,493 $45.8 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $16.3 Million - $19.9 Million
231,409 New
231,409 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $4.82 Million - $6.03 Million
72,771 Added 137.24%
125,795 $8.38 Million
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $3.51 Million - $4.41 Million
53,024 New
53,024 $4.03 Million
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $22.8 Million - $27.5 Million
-345,343 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $11.8 Million - $13.8 Million
186,794 Added 117.81%
345,343 $25.3 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $10.3 Million - $12.6 Million
150,528 Added 1876.67%
158,549 $10.9 Million
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $3.82 Million - $4.18 Million
-47,787 Reduced 85.63%
8,021 $675,000
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $3.83 Million - $5.07 Million
50,438 Added 939.26%
55,808 $4.54 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $1.23 Million - $1.49 Million
-15,244 Reduced 73.95%
5,370 $467,000
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $1.75 Million - $2.26 Million
20,614 New
20,614 $1.85 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $7.59 Million - $11.2 Million
-102,370 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $22.2 Million - $30.3 Million
-352,079 Reduced 77.47%
102,370 $7.5 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $27.9 Million - $36.6 Million
382,607 Added 532.57%
454,449 $39.7 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $1.77 Million - $2.11 Million
24,359 Added 51.3%
71,842 $5.33 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $3.49 Million - $4.21 Million
47,483 New
47,483 $4.03 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $7.42 Million - $8.87 Million
-126,860 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $7.47 Million - $8.98 Million
121,019 Added 2071.89%
126,860 $8.76 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $355,424 - $490,527
5,841 New
5,841 $391,000
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $12.1 Million - $14.7 Million
-145,120 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $10.4 Million - $13 Million
111,369 Added 329.97%
145,120 $13.7 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $3.68 Million - $4.67 Million
33,751
33,751 $3.94 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.